Success Story The 100th CX for the SHL Plant in ... - Krauss Maffei

Success Story
The 100th CX for the
SHL Plant in Taiwan
Engineering Passion

Special Print, Ahead KraussMaffei, Ausgabe 01/12
Roger Samuelsson
CEO and founder of SHL Group
Modern & synchronized assembly forms the basis
for production involving tight tolerances
SHL (Scandinavian Health Ltd.),
with over 1,800 employees
globally, is the world’s largest
privately­owned designer,
developer and manufacturer of
advanced drug delivery devices
for the biopharmaceutical industry,
such as auto injectors,
pen injectors and inhalers.
The company was established in 1989
with the goal of combining world­class
manufacturing in Asia with inter national
management practices. There are more
than 100 injection molding machines at
SHL’s facilities in Asia, with a clamping
force range of 50 to 420 tons. All machines
are equipped with either 6­axis or linear
robots. Machine types range from hydraulic
to hybrid and fully electrical machines,
as well as multi­component machines
with turntable and indexing technology.
High precision, high capacity
When manufacturing single­use disposable
injection systems, such as auto injectors,
the quality of all components must be
absolutely identical. Thus, verifiable compliance
with the most stringent quality
standards must be guaranteed when
running production 24/7. KraussMaffei’s
CX machines, with different clamping
forces, have been certified for their designated
scope of delivery and performance
characteristics. The quality requirements
were configured according to the types of
components installed and set within the
maximum permissible noise emissions
and maximum tolerances of the shot
weight. “With the CX series of machines,
we have further enhanced reliability
and continue to produce consistent high
quality components”, emphasizes Roger
Samuelsson, CEO and Founder of the SHL
Group, “this has always been a hallmark
of SHL”.
High degree of transparency
With one of the most modern & synchronized
assemblies with comprehensive documentation,
KraussMaffei has established
a transparent basis for manufacturing
within tight tolerances. This allows us to
build a machine optimized for producing
molded parts. Where necessary, the machines
can also be designed and qualified
according to Good Manufacturing Practice
guidelines which include required documentation.
When it comes to produ cing
molded parts, quality can be disting uished
by process reliability and the exact
“ As a global manufacturer of drug delivery
devices for the biopharmaceutical industry,
the key to our company’s success
has been the high quality of our products.
We utilize precise manufacturing that is
proven and reproducible. And our goal is
zero error tolerance, a goal that our partners
must share with us. KraussMaffei is
a good example of such a partner.”
repeatability of the single components,
and this is where synchronized assembly
plays a crucial role. The synchronized
assembly of injection molding machines
with clamping forces of 35 to 350 tons
means both the assembly and commissioning
of each machine are synchronized
in twelve cycle steps. Introduced in 2005,
synchronized assembly has continuously
improved thanks to employees’ flexibility
and willingness to work together. This
can be seen, in particular, in the high
quality of deliveries and the short throughput
times. We now use KAIZEN, a well­
established system, as a general concept
for continuous improvement processes.
“Our goal is to achieve the highest possible
customer satisfaction”, explains Michael
Müller, Vice President of KraussMaffei in
China, “and an example of our success in
achieving such a goal can be demonstrated
by looking at our relationship with one of
our longstanding customers, SHL, where
we just delivered the 100th KraussMaffei
machine last December, to their facilities
in Taoyuan, Taiwan”.